跳至主要内容
临床试验/IRCT2014092819316N1
IRCT2014092819316N1已完成2 期

The efficacy of pentoxifylline in prevention of contrast-induced nephropathy in patients with myocardial infarction undergoing coronary angioplasty: A randomized clinical trial

Vice chancellor for research of Mashhad University of Medical Sciences0 个研究点目标入组 182 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
182

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 85 years(—)
性别
All

入选标准

  • Consent to participate; ST elevation myocardial infarction (STMI) and age over 18 years. Exclusion criteria: serum creatinine more than 1.5 mg/dl, heart failure; history of end-stage renal failure or being on dialysis; use of N-acetyl cysteine, theophylline, aminoglycosides, and nonsteroidal anti-inflammatory drugs; intravenous contrast media administration within the past two days; pulmonary edema; multiple myeloma; and uncontrolled hypertension

排除标准

  • 未提供

研究者

发起方
Vice chancellor for research of Mashhad University of Medical Sciences

相似试验